| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba090c867801ab7bccb082f1b694ad25 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445 |
| filingDate |
1991-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cba3d124a7d64631a21c82daada17373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da1c661bbd09b401c20bbc4144c0f8e |
| publicationDate |
1992-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9200735-A1 |
| titleOfInvention |
Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease |
| abstract |
The present invention relates to the dopamine D2-receptor antagonist, domperidone and the D2-receptor agonist, ropinirole for use in the treatment of Parkinson's disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8303986-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9706786-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323035-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8460706-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3175848-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6316027-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2343060-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9323035-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7927624-B2 |
| priorityDate |
1990-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |